2Colleen A McHomey, John E Ware, Anastasia E Raczek. The MOS 36-item short-form health survey(SF-36) :Ⅱ. Psychometric and ellnieal tests of validity in measuring physical and mental health constructs [ J]. Medical Care, 1993,31 (3) :247 被引量：1
3Chesnut CH. Tiludronate : development as an osteoporosis therapy[ J ]. Bone, 1995,17(5 Suppl) :517 - 519 被引量：1
4Josse RG. Prevention and management of osteoporosis : consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 3. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women[J]. Can Med Assoc J, 1996,155(7) :929 - 934 被引量：1
5Johnell O. Advances in osteporosis:better identification of risk factors can reduce morbidity and mortality[ J]. J Intern Med, 1996,239 (4) : 299 - 304 被引量：1
6Clinical practice guidelines for the diagnosis and management of osteoporosis. Scientific Advisory Board, Osteoporosis Society of Canada[ J]. Can Med Assoc J, 1996,155(8) : 1113 - 1133 被引量：1
